Differential Cerebral Gene Expression During Cardiopulmonary Bypass in the Rat: Evidence for Apoptosis?

Authors:
  • YSYukie Sato
    Yukie Sato
  • DLDaniel T. Laskowitz
    Daniel T. Laskowitz
  • EBEllen R. Bennett
    Ellen R. Bennett
  • MNMark F. Newman
    Mark F. Newman
  • DWDavid S. Warner
    David S. Warner
  • HGHilary P. Grocott
    Hilary P. Grocott

Abstract
Subjected to 90 min of normothermic CPB. A group of sham-operated rats (n = 7) served as non-CPB controls. After a 3-h post-CPB period of recovery, their brains were removed, homogenized, and processed for messenger RNA (mRNA) extraction. By using a ribonuclease protection assay, the ratios of both pro- and antiapoptotic mRNA (bcl-x, bcl-2, bax, caspase 2, and caspase 3) to the housekeeping glyceraldehyde phosphate dehydrogenase (GAPDH) gene were determined. Additionally, Western immunoblotting was performed to detect the presence of activated caspase 3, a protein central in the apoptotic process. Compared with the non-CPB controls, the CPB group had significantly increased levels of apoptotic/GAPDH mRNA ratios (bcl-x, 0.414 ± 0.152 CPB versus 0.251 ± 0.051 non-CPB, P = 0.048; caspase 2, 0.030 ± 0.014 CPB versus 0.018 ± 0.005 non-CPB, P = 0.048; bax, 0.106 ± 0.035 CPB versus 0.066 ± 0.009 non-CPB, P = 0.009; bcl-2, 0.011 ± 0.006 CPB versus 0.006 ± 0.002 non-CPB, P = 0.035). However, no activated caspase 3 protein was detected in either group. Elucidating the molecular biological sequelae of CPB may aid in the understanding of the pathophysiology of cardiac surgery-associated cerebral injury and, in doing so, may be useful in identifying potential therapeutic targets for pharmacologic neuroprotection....

This publication has 35 references indexed in Scilit: